Results
|
|
41.
|
A Phase II Randomized Trial (GO27827) of First-Line FOLFOX Plus Bevacizumab with or Without the MET Inhibitor Onartuzumab in Patients with Metastatic Colorectal Cancer. [electronic resource] by
- Bendell, Johanna C
- Hochster, Howard
- Hart, Lowell L
- Firdaus, Irfan
- Mace, Joseph R
- McFarlane, Joshua J
- Kozloff, Mark
- Catenacci, Daniel
- Hsu, Jessie J
- Hack, Stephen P
- Shames, David S
- Phan, See-Chun
- Koeppen, Hartmut
- Cohn, Allen L
Producer: 20180216
In:
The oncologist vol. 22
Availability: No items available.
|
|
|
42.
|
Circulating Tumor DNA Sequencing Analysis of Gastroesophageal Adenocarcinoma. [electronic resource] by
- Maron, Steven B
- Chase, Leah M
- Lomnicki, Samantha
- Kochanny, Sara
- Moore, Kelly L
- Joshi, Smita S
- Landron, Stacie
- Johnson, Julie
- Kiedrowski, Lesli A
- Nagy, Rebecca J
- Lanman, Richard B
- Kim, Seung Tae
- Lee, Jeeyun
- Catenacci, Daniel V T
Producer: 20200921
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 25
Availability: No items available.
|
|
|
43.
|
Phase I Study of AMG 337, a Highly Selective Small-molecule MET Inhibitor, in Patients with Advanced Solid Tumors. [electronic resource] by
- Hong, David S
- LoRusso, Patricia
- Hamid, Omid
- Janku, Filip
- Kittaneh, Muaiad
- Catenacci, Daniel V T
- Chan, Emily
- Bekaii-Saab, Tanios
- Gadgeel, Shirish M
- Loberg, Robert D
- Amore, Benny M
- Hwang, Yuying C
- Tang, Rui
- Ngarmchamnanrith, Gataree
- Kwak, Eunice L
Producer: 20190703
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 25
Availability: No items available.
|
|
|
44.
|
Targeted Therapies for Targeted Populations: Anti-EGFR Treatment for [electronic resource] by
- Maron, Steven B
- Alpert, Lindsay
- Kwak, Heewon A
- Lomnicki, Samantha
- Chase, Leah
- Xu, David
- O'Day, Emily
- Nagy, Rebecca J
- Lanman, Richard B
- Cecchi, Fabiola
- Hembrough, Todd
- Schrock, Alexa
- Hart, John
- Xiao, Shu-Yuan
- Setia, Namrata
- Catenacci, Daniel V T
Producer: 20190906
In:
Cancer discovery vol. 8
Availability: No items available.
|
|
|
45.
|
Clinical Assessment of 5-Fluorouracil/Leucovorin, Nab-Paclitaxel, and Irinotecan (FOLFIRABRAX) in Untreated Patients with Gastrointestinal Cancer Using [electronic resource] by
- Joshi, Smita S
- Catenacci, Daniel V T
- Karrison, Theodore G
- Peterson, Jaclyn D
- Zalupski, Mark M
- Sehdev, Amikar
- Wade, James
- Sadiq, Ahad
- Picozzi, Vincent J
- Amico, Andrea
- Marsh, Robert
- Kozloff, Mark F
- Polite, Blase N
- Kindler, Hedy L
- Sharma, Manish R
Producer: 20201001
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 26
Availability: No items available.
|
|
|
46.
|
Efficacy and Safety of Trifluridine/Tipiracil Treatment in Patients With Metastatic Gastric Cancer Who Had Undergone Gastrectomy: Subgroup Analyses of a Randomized Clinical Trial. [electronic resource] by
- Ilson, David H
- Tabernero, Josep
- Prokharau, Aliaksandr
- Arkenau, Hendrik-Tobias
- Ghidini, Michele
- Fujitani, Kazumasa
- Van Cutsem, Eric
- Thuss-Patience, Peter
- Beretta, Giordano D
- Mansoor, Wasat
- Zhavrid, Edvard
- Alsina, Maria
- George, Ben
- Catenacci, Daniel
- McGuigan, Sandra
- Makris, Lukas
- Doi, Toshihiko
- Shitara, Kohei
Producer: 20220310
In:
JAMA oncology vol. 6
Availability: No items available.
|
|
|
47.
|
Pembrolizumab for patients with PD-L1-positive advanced gastric cancer (KEYNOTE-012): a multicentre, open-label, phase 1b trial. [electronic resource] by
- Muro, Kei
- Chung, Hyun Cheol
- Shankaran, Veena
- Geva, Ravit
- Catenacci, Daniel
- Gupta, Shilpa
- Eder, Joseph Paul
- Golan, Talia
- Le, Dung T
- Burtness, Barbara
- McRee, Autumn J
- Lin, Chia-Chi
- Pathiraja, Kumudu
- Lunceford, Jared
- Emancipator, Kenneth
- Juco, Jonathan
- Koshiji, Minori
- Bang, Yung-Jue
Producer: 20170605
In:
The Lancet. Oncology vol. 17
Availability: No items available.
|
|
|
48.
|
Absolute quantitation of Met using mass spectrometry for clinical application: assay precision, stability, and correlation with MET gene amplification in FFPE tumor tissue. [electronic resource] by
- Catenacci, Daniel V T
- Liao, Wei-Li
- Thyparambil, Sheeno
- Henderson, Les
- Xu, Peng
- Zhao, Lei
- Rambo, Brittany
- Hart, John
- Xiao, Shu-Yuan
- Bengali, Kathleen
- Uzzell, Jamar
- Darfler, Marlene
- Krizman, David B
- Cecchi, Fabiola
- Bottaro, Donald P
- Karrison, Theodore
- Veenstra, Timothy D
- Hembrough, Todd
- Burrows, Jon
Producer: 20151106
In:
PloS one vol. 9
Availability: No items available.
|
|
|
49.
|
First-in-Man Phase I Trial of the Selective MET Inhibitor Tepotinib in Patients with Advanced Solid Tumors. [electronic resource] by
- Falchook, Gerald S
- Kurzrock, Razelle
- Amin, Hesham M
- Xiong, Wenyuan
- Fu, Siqing
- Piha-Paul, Sarina A
- Janku, Filip
- Eskandari, Ghazaleh
- Catenacci, Daniel V
- Klevesath, Manfred
- Bruns, Rolf
- Stammberger, Uz
- Johne, Andreas
- Bladt, Friedhelm
- Friese-Hamim, Manja
- Girard, Pascal
- El Bawab, Samer
- Hong, David S
Producer: 20210114
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 26
Availability: No items available.
|
|
|
50.
|
Phase II study evaluating 2 dosing schedules of oral foretinib (GSK1363089), cMET/VEGFR2 inhibitor, in patients with metastatic gastric cancer. [electronic resource] by
- Shah, Manish A
- Wainberg, Zev A
- Catenacci, Daniel V T
- Hochster, Howard S
- Ford, James
- Kunz, Pamela
- Lee, Fa-Chyi
- Kallender, Howard
- Cecchi, Fabiola
- Rabe, Daniel C
- Keer, Harold
- Martin, Anne-Marie
- Liu, Yuan
- Gagnon, Robert
- Bonate, Peter
- Liu, Li
- Gilmer, Tona
- Bottaro, Donald P
Producer: 20130912
In:
PloS one vol. 8
Availability: No items available.
|
|
|
51.
|
Biliary cancer: Utility of next-generation sequencing for clinical management. [electronic resource] by
- Javle, Milind
- Bekaii-Saab, Tanios
- Jain, Apurva
- Wang, Ying
- Kelley, Robin Katie
- Wang, Kai
- Kang, Hyunseon C
- Catenacci, Daniel
- Ali, Siraj
- Krishnan, Sunil
- Ahn, Daniel
- Bocobo, Andrea Grace
- Zuo, Mingxin
- Kaseb, Ahmed
- Miller, Vincent
- Stephens, Philip J
- Meric-Bernstam, Funda
- Shroff, Rachna
- Ross, Jeffrey
Producer: 20170523
In:
Cancer vol. 122
Availability: No items available.
|
|
|
52.
|
Mass-spectrometry-based quantitation of Her2 in gastroesophageal tumor tissue: comparison to IHC and FISH. [electronic resource] by
- Catenacci, Daniel V T
- Liao, Wei-Li
- Zhao, Lei
- Whitcomb, Emma
- Henderson, Les
- O'Day, Emily
- Xu, Peng
- Thyparambil, Sheeno
- Krizman, David
- Bengali, Kathleen
- Uzzell, Jamar
- Darfler, Marlene
- Cecchi, Fabiola
- Blackler, Adele
- Bang, Yung-Jue
- Hart, John
- Xiao, Shu-Yuan
- Lee, Sang Mee
- Burrows, Jon
- Hembrough, Todd
Producer: 20170307
In:
Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association vol. 19
Availability: No items available.
|
|
|
53.
|
Analysis of DNA Damage Response Gene Alterations and Tumor Mutational Burden Across 17,486 Tubular Gastrointestinal Carcinomas: Implications for Therapy. [electronic resource] by
- Parikh, Aparna R
- He, Yuting
- Hong, Ted S
- Corcoran, Ryan B
- Clark, Jeff W
- Ryan, David P
- Zou, Lee
- Ting, David T
- Catenacci, Daniel V
- Chao, Joseph
- Fakih, Marwan
- Klempner, Samuel J
- Ross, Jeffrey S
- Frampton, Garrett M
- Miller, Vincent A
- Ali, Siraj M
- Schrock, Alexa B
Producer: 20200806
In:
The oncologist vol. 24
Availability: No items available.
|
|
|
54.
|
Prospective comprehensive genomic profiling of advanced gastric carcinoma cases reveals frequent clinically relevant genomic alterations and new routes for targeted therapies. [electronic resource] by
- Ali, Siraj M
- Sanford, Eric M
- Klempner, Samuel J
- Rubinson, Douglas A
- Wang, Kai
- Palma, Norma A
- Chmielecki, Juliann
- Yelensky, Roman
- Palmer, Gary A
- Morosini, Deborah
- Lipson, Doron
- Catenacci, Daniel V
- Braiteh, Fadi
- Erlich, Rachel
- Stephens, Philip J
- Ross, Jeffrey S
- Ou, Sai-Hong Ignatius
- Miller, Vincent A
Producer: 20160411
In:
The oncologist vol. 20
Availability: No items available.
|
|
|
55.
|
New routes to targeted therapy of intrahepatic cholangiocarcinomas revealed by next-generation sequencing. [electronic resource] by
- Ross, Jeffrey S
- Wang, Kai
- Gay, Laurie
- Al-Rohil, Rami
- Rand, Janne V
- Jones, David M
- Lee, Hwa J
- Sheehan, Christine E
- Otto, Geoff A
- Palmer, Gary
- Yelensky, Roman
- Lipson, Doron
- Morosini, Deborah
- Hawryluk, Matthew
- Catenacci, Daniel V T
- Miller, Vincent A
- Churi, Chaitanya
- Ali, Siraj
- Stephens, Philip J
Producer: 20150112
In:
The oncologist vol. 19
Availability: No items available.
|
|
|
56.
|
Pembrolizumab alone or in combination with chemotherapy as first-line therapy for patients with advanced gastric or gastroesophageal junction adenocarcinoma: results from the phase II nonrandomized KEYNOTE-059 study. [electronic resource] by
- Bang, Yung-Jue
- Kang, Yoon-Koo
- Catenacci, Daniel V
- Muro, Kei
- Fuchs, Charles S
- Geva, Ravit
- Hara, Hiroki
- Golan, Talia
- Garrido, Marcelo
- Jalal, Shadia I
- Borg, Christophe
- Doi, Toshihiko
- Yoon, Harry H
- Savage, Mary J
- Wang, Jiangdian
- Dalal, Rita P
- Shah, Sukrut
- Wainberg, Zev A
- Chung, Hyun Cheol
Producer: 20191230
In:
Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association vol. 22
Availability: No items available.
|
|
|
57.
|
Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study. [electronic resource] by
- Abou-Alfa, Ghassan K
- Sahai, Vaibhav
- Hollebecque, Antoine
- Vaccaro, Gina
- Melisi, Davide
- Al-Rajabi, Raed
- Paulson, Andrew S
- Borad, Mitesh J
- Gallinson, David
- Murphy, Adrian G
- Oh, Do-Youn
- Dotan, Efrat
- Catenacci, Daniel V
- Van Cutsem, Eric
- Ji, Tao
- Lihou, Christine F
- Zhen, Huiling
- Féliz, Luis
- Vogel, Arndt
Producer: 20200709
In:
The Lancet. Oncology vol. 21
Availability: No items available.
|
|
|
58.
|
Rilotumumab plus epirubicin, cisplatin, and capecitabine as first-line therapy in advanced MET-positive gastric or gastro-oesophageal junction cancer (RILOMET-1): a randomised, double-blind, placebo-controlled, phase 3 trial. [electronic resource] by
- Catenacci, Daniel V T
- Tebbutt, Niall C
- Davidenko, Irina
- Murad, André M
- Al-Batran, Salah-Eddin
- Ilson, David H
- Tjulandin, Sergei
- Gotovkin, Evengy
- Karaszewska, Boguslawa
- Bondarenko, Igor
- Tejani, Mohamedtaki A
- Udrea, Anghel A
- Tehfe, Mustapha
- De Vita, Ferdinando
- Turkington, Cheryl
- Tang, Rui
- Ang, Agnes
- Zhang, Yilong
- Hoang, Tien
- Sidhu, Roger
- Cunningham, David
Producer: 20171215
In:
The Lancet. Oncology vol. 18
Availability: No items available.
|
|
|
59.
|
Extremely high genetic diversity in a single tumor points to prevalence of non-Darwinian cell evolution. [electronic resource] by
- Ling, Shaoping
- Hu, Zheng
- Yang, Zuyu
- Yang, Fang
- Li, Yawei
- Lin, Pei
- Chen, Ke
- Dong, Lili
- Cao, Lihua
- Tao, Yong
- Hao, Lingtong
- Chen, Qingjian
- Gong, Qiang
- Wu, Dafei
- Li, Wenjie
- Zhao, Wenming
- Tian, Xiuyun
- Hao, Chunyi
- Hungate, Eric A
- Catenacci, Daniel V T
- Hudson, Richard R
- Li, Wen-Hsiung
- Lu, Xuemei
- Wu, Chung-I
Producer: 20160315
In:
Proceedings of the National Academy of Sciences of the United States of America vol. 112
Availability: No items available.
|
|
|
60.
|
RON (MST1R) is a novel prognostic marker and therapeutic target for gastroesophageal adenocarcinoma. [electronic resource] by
- Catenacci, Daniel V T
- Cervantes, Gustavo
- Yala, Soheil
- Nelson, Erik A
- El-Hashani, Essam
- Kanteti, Rajani
- El Dinali, Mohamed
- Hasina, Rifat
- Brägelmann, Johannes
- Seiwert, Tanguy
- Sanicola, Michele
- Henderson, Les
- Grushko, Tatyana A
- Olopade, Olufunmilayo
- Karrison, Theodore
- Bang, Yung-Jue
- Kim, Woo Ho
- Tretiakova, Maria
- Vokes, Everett
- Frank, David A
- Kindler, Hedy L
- Huet, Heather
- Salgia, Ravi
Producer: 20111108
In:
Cancer biology & therapy vol. 12
Availability: No items available.
|